arrow
Back
U

Ugo De Giorgi

university oncology unit

79H-index
979Paper Count
3.0WCitation Count
Published Papers 345
Publication Date
Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter study
err2026-08-04
err0
errOAAI
errMarianna Garofoli; Maria Iole Natalicchio; Giuseppina Bruno; Aldo Rosano; Brigida Anna Maiorano; Sabrina Rossetti; Sarah Scagliarini; Lorena Incorvaia; Luigi Formisano; Ilaria Toma; Guido Giordano; Giovanna Pecoraro; Francesco Grillone; Laura Palumbo; Marco Pisino; Marta Palladino; Concetta Rita Di Pippo; Valeria Bafunno; Nicole Brighi; Chiara Casadei; Cristian Lolli; Maria Concetta Cursano; Vincenzo Emanuele Chiuri; Pasquale Rescigno; Emiliano Tamburini; Francesca Sanguedolce; Fabio Calabrò; Ugo De Giorgi; Matteo Landriscina; Vincenza Conteduca
errShare
errSave
DURATION OF TREATMENT SUSPENSION AMONG ALL RANDOMIZED PATIENTS IN EMBARK
err2026-05-01
err0
PREAI
errShore, Neal D.; Sieber, Paul R.; De Giorgi, Ugo; Danila, Daniel C.; Dunshee, Curtis J.; Lallas, Costas D.; Pliskin, Marc J.; Morgans, Alicia K.; Tang, Yiyun; Rosales, Matt; Wang, Fong; Kennedy, Dana; Freedland, Stephen J.
errShare
errSave
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial
err2026-05-01
err6
PREAI
errShore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J.
errShare
errSave
The Prognostic Power of miR-21 in Breast Cancer: A Systematic Review and Meta-Analysis
err2026-03-03
err0
errOAAI
errLuana Conte; Maria Rosaria Tumolo; Giorgio De Nunzio; Ugo De Giorgi; Roberto Guarino; Donato Cascio; Federico Cucci
errShare
errSave
Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges
err2025-12-18
err0
errOAAI
errNeal D. Shore; Stephen J. Freedland; Lisa G. Horvath; Joe M. O’Sullivan; Ugo De Giorgi; Edward C. Ray; Ashley E. Ross; Yiyun Tang; David Russell; Kenneth K. Iwata; Matt Rosales; Arijit Ganguli; Bertrand Tombal
errShare
errSave
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study
err2025-11-27
err0
errOAAI
errIrene Marini; Emilio Francesco Giunta; Silvia Nicolini; Ilaria Grassi; Flavia Foca; Anna Sarnelli; Valentina Di Iorio; Lilla Vizza; Erika Giani; Monica Celli; Manuela Monti; Stefano Severi; Ugo De Giorgi; Francesca Borgia; Giovanni Paganelli; Federica Matteucci; Maddalena Sansovini
errShare
errSave
Corrigendum to Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study [European Journal of Cancer Volume 213, December 2024, 115078]
err2025-11-13
err0
PREAI
errArun A. Azad; Karim Fizazi; Nobuaki Matsubara; Fred Saad; Ugo De Giorgi; Jae Young Joung; Peter C.C. Fong; Robert J. Jones; Stefanie Zschäbitz; Jan Oldenburg; Neal D. Shore; Curtis Dunshee; Joan Carles; Andre P. Fay; Xun Lin; Liza DeAnnuntis; Nicola Di Santo; Michael A. Zielinski; Neeraj Agarwal
errShare
errSave
Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)
err2025-10-13
err0
errOAAI
errMarco Stellato; Pierangela Sepe; Enrico Bronte; Vincenza Conteduca; Maria Cossu Rocca; Ugo De Giorgi; Marilena Di Napoli; Luca Galli; Lorena Incorvaia; Luca Lalli; Brigida Anna Maiorano; Marco Maruzzo; Alessia Mennitto; Giandomenico Roviello; Matteo Santoni; Mariella Sorarù; Elisa Zanardi; Paolo Zucali; Giuseppe Procopio; Elena Verzoni
errShare
errSave
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
err2025-09-29
err0
errOAAI
errPaolo Marchetti; Giuseppe Curigliano; Mauro Biffoni; Sara Lonardi; Simone Scagnoli; Lorenzo Fornaro; Valentina Guarneri; Ugo De Giorgi; Paolo Antonio Ascierto; Giovanni Blandino; Giulia D’Amati; Massimo Aglietta; Chiara Cremolini; Pierfranco Conte; Edoardo Crimini; Maurizio Ceracchi; Simona Pisegna; Sofia Verkhovskaia; Roberto Bordonaro; Sergio Bracarda; Giovanni Butturini; Lucia Del Mastro; Andrea DeCensi; Agnese Fabbri; Elisabetta Fenocchio; Stefania Gori; Giulio Metro; Annamaria Pessino; Daniele Pozzessere; Fabio Puglisi; Stefano Tamberi; Alberto Zambelli; Donatella Marino; Ettore Capoluongo; Federico Cappuzzo; Bruna Cerbelli; Giuseppe Giannini; Umberto Malapelle; Federica Mazzuca; Marianna Nuti; Giancarlo Pruneri; Maurizio Simmaco; Lidia Strigari; Giuseppe Tonini; Nello Martini; Andrea Botticelli
errShare
errSave
Impact of treatment suspension on health-related quality of life in the EMBARK trial: a post hoc analysis
err2025-08-14
err0
PREAI
errStephen J. Freedland; Ugo De Giorgi; Antti Rannikko; Fred Saad; Miguel Ramirez-Backhaus; Anchen F. Nasr; Jasmina I. Ivanova; Arijit Ganguli; Pavol Kral; Arlene L. Reisman; Neal D. Shore
errShare
errSave
Effectiveness of nivolumab-based immunotherapy and prognostic stratification by the Meet-URO score in real-world older patients with metastatic renal cell carcinoma
err2025-08-12
err0
PREAI
errVeronica Murianni; Marina Campione; Malvina Cremante; Umberto Basso; Lucia Fratino; Sebastiano Buti; Sergio Bracarda; Marco Maruzzo; Ugo De Giorgi; Giampaolo Tortora; Silvia Chiellino; Lorenzo Antonuzzo; Luca Galli; Paolo Andrea Zucali; Mimma Rizzo; Alessio Signori; Diana Giannarelli; Giuseppe Procopio; Pasquale Rescigno; Giuseppe Fornarini; Sara Elena Rebuzzi; Giuseppe Luigi Banna
errShare
errSave
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
err2025-07-27
err0
errOAAI
errMaria T. Bourlon†; Luca Galli†; Enrique Grande; Se Hoon Park; Bohuslav Melichar; Timothy J. Schieber; Maria José Juan-Fita; Yüksel Ürün; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Ugo De Giorgi; Jakub Kucharz; Esther Pérez Calabuig; Vincenza Conteduca; Tarek Taha; Pasquale Rescigno; Hussam Abu-Sini; Gian Paolo Spinelli; Ray Manneh Kopp; Alessia Salfi; Dipen Bhuva; Paola Valdez-Sandoval; Sofia Mendez-Bribiesca; Ondrej Fiala; Sebastiano Buti; Fernando Sabino Marques Monteiro; Aristotelis Bamias; Marwan Ghosn; Francesco Massari; Jawaher Ansari‡; Matteo Santoni‡
errShare
errSave
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
err2025-07-16
err0
PREAI
errNeeraj Agarwal; Arun A Azad; Joan Carles; André P Fay; Nobuaki Matsubara; Cezary Szczylik; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Fred Saad; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Xun Lin; Cynthia G Healy; Matko Kalac; Dana Kennedy; Karim Fizazi
errShare
errSave
Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
err2025-07-16
err0
PREAI
errKarim Fizazi; Arun A Azad; Nobuaki Matsubara; Joan Carles; André P Fay; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Dingwei Ye; Xun Lin; Matko Kalac; A Douglas Laird; Dana Kennedy; Neeraj Agarwal
errShare
errSave
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study
err2025-05-28
err0
PREAI
errShilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
errShare
errSave
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study☆
err2025-05-16
err0
PREAI
errC. Gratzke; M. Özgüroğlu; A. Peer; M.A.N. Sendur; M. Retz; J.C. Goh; W. Loidl; G. Jayram; S.-S. Byun; C. Kwak; M. Kwiatkowski; R. Manneh Kopp; J.C.V. Limón; J.F.E. Penagos; U. De Giorgi; K.M. da Trindade; C. Niu; Y. Liu; C.H. Poehlein; J.M. Piulats
errShare
errSave
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study
err2025-05-15
err0
PREAI
errSoraia Lobo-Martins; Veronique Debien; Elisa Agostinetto; Marianna Sirico; Giselle de Souza Carvalho; Flavia Jacobs; Chiara Molinelli; Renata Colombo Bonadio; Pedro Bergmann; Cristiano de Pádua Souza; Laura Testa; Marina Nishimuni; André João Rossi; Gabriel Kamei Guimarães; Michel Moreau; Ugo De Giorgi; José Bines; Armando Santoro; Donatienne Taylor; Francois P. Duhoux; Giacomo Barchiesi; Matteo Lambertini; Martine Piccart; Evandro de Azambuja
errShare
errSave
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON-1 study
err2025-05-09
err0
errOAAI
errPorta, Camillo; Massari, Francesco; Taha, Tarek; Grande, Enrique; Bourlon, Maria T.; Kanesvaran, Ravindran; Basso, Umberto; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Myint, Zin W.; Fornarini, Giuseppe; Buttner, Thomas; Park, Se Hoon; Urun, Yueksel; De Giorgi, Ugo; Pichler, Renate; Rescigno, Pasquale; Buchler, Tomas; Studentova, Hana; Melichar, Bohuslav; Ansari, Jawaher; Mollica, Veronica; Kucharz, Jakub; Rizzo, Mimma; Rizzo, Alessandro; Kopp, Ray Manneh; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Bamias, Aristotelis; Santoni, Matteo
errShare
errSave
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants
err2025-05-08
err0
errOAAI
errPalleschi, Michela; Virga, Alessandra; Scarpi, Emanuela; Fonzi, Eugenio; Musolino, Antonino; Merloni, Filippo; Sarti, Samanta; Danesi, Rita; Ravegnani, Mila; Casadei, Chiara; Sirico, Marianna; Gianni, Caterina; Maltoni, Roberta; Bravaccini, Sara; Calistri, Daniele; Arcangeli, Valentina; Zampiga, Valentina; Cangini, Ilaria; Bandini, Erika; Mannozzi, Francesca; Falcini, Fabio; Martinelli, Giovanni; De Giorgi, Ugo; Ulivi, Paola; Tedaldi, Gianluca
errShare
errSave
Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK
err2025-03-26
err0
errOAAI
errDe Giorgi, Ugo; Freedland, Stephen J.; Ramirez-Backhaus, Miguel; Villers, Arnauld; Tarazi, Jamal; Tang, Yiyun; Haas, Gabriel P.; Rosales, Matt
errShare
errSave